A BILL 
To amend the Public Health Service Act to strengthen pro-
gram integrity and enhance low-income patient benefits 
for safety net providers. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘340B Protection and 
4
Accountability Act of 2019’’. 
5
SEC. 2. STRENGTHENING 340B PROGRAM INTEGRITY AND 
6
ENHANCING LOW-INCOME PATIENT BENE-
7
FITS FOR SAFETY NET PROVIDERS. 
8
(a) DEFINITION OF PATIENT.—Section 340B(b) of 
9
the Public Health Service Act (42 U.S.C. 256b(b)) is 
10
18:53 Mar 21, 2019
H1559
2 
•HR 1559 IH
amended by adding at the end the following new para-
1
graph: 
2
‘‘(3) PATIENT.— 
3
‘‘(A) IN
GENERAL.—In this section, the 
4
term ‘patient’ means, with respect to a covered 
5
entity described in subparagraph (L) or (M) of 
6
subsection (a)(4), an individual who, on a pre-
7
scription-by-prescription 
or 
order-by-order 
8
basis— 
9
‘‘(i) receives a health care service at a 
10
covered entity or an outpatient hospital fa-
11
cility described in subsection (c)(3) which 
12
is registered for the drug discount program 
13
under this section and listed on the public 
14
internet website of the Department of 
15
Health and Human Services relating to 
16
this section; 
17
‘‘(ii) receives an outpatient in-person 
18
health care service from a health care pro-
19
vider employed by the covered entity or 
20
who is an independent contractor of the 
21
covered entity, such that the covered entity 
22
bills for services on behalf of the provider; 
23
‘‘(iii) receives a drug that is ordered 
24
or prescribed by the covered entity pro-
25
18:53 Mar 21, 2019
H1559
3 
•HR 1559 IH
vider, including any renewals of existing 
1
prescriptions, as a result of the service de-
2
scribed in clause (ii); 
3
‘‘(iv) in the case of a covered entity 
4
that has a contract with a State or local 
5
government described in subclause (III) of 
6
subsection (a)(4)(L)(i), receives a health 
7
care service or range of such services, to 
8
include the ordering or prescribing of a 
9
covered outpatient drug, from the covered 
10
entity pursuant to such contract; 
11
‘‘(v) is classified as an outpatient 
12
when the drug is ordered or prescribed, as 
13
demonstrated by how the service was reim-
14
bursed by the applicable payer, or, where 
15
the covered entity does not seek such reim-
16
bursement, how the service would have 
17
been reimbursed under title XVIII of the 
18
Social Security Act; and 
19
‘‘(vi) has a relationship with the cov-
20
ered entity such that the covered entity 
21
creates and maintains auditable health 
22
care records which demonstrate that— 
23
18:53 Mar 21, 2019
H1559
4 
•HR 1559 IH
‘‘(I) the covered entity has a pro-
1
vider-to-patient relationship with the 
2
individual; and 
3
‘‘(II) responsibility for the indi-
4
vidual’s health care service that re-
5
sulted in the prescription or order for 
6
the drug described in clause (iii) is 
7
with the covered entity. 
8
‘‘(B) EXCLUSIONS.—For purposes of this 
9
section, an individual shall not be considered a 
10
patient of a covered entity described in sub-
11
paragraph (L) or (M) of subsection (a)(4) if— 
12
‘‘(i) the individual is an inmate of a 
13
correctional facility; 
14
‘‘(ii) the health care service described 
15
in clause (ii) of subparagraph (A) received 
16
by the individual from the covered entity 
17
consists only of the administration or infu-
18
sion of a drug or drugs, or the dispensing 
19
of a drug or drugs for subsequent self-ad-
20
ministration or administration in the home 
21
setting, without a covered entity provider- 
22
to-patient encounter; 
23
‘‘(iii) the health care service described 
24
in clause (ii) of subparagraph (A) received 
25
18:53 Mar 21, 2019
H1559
5 
•HR 1559 IH
by the individual from the covered entity is 
1
provided by a health care organization that 
2
has only an affiliation arrangement with 
3
the covered entity, even if the covered enti-
4
ty has access to the affiliated organiza-
5
tion’s records; or 
6
‘‘(iv) the primary relationship between 
7
the individual and the covered entity is one 
8
of employment. 
9
‘‘(C) REGULATIONS.—Not later than 180 
10
days after the date of enactment of the 340B 
11
Protection and Accountability Act of 2019, the 
12
Secretary shall promulgate final regulations 
13
through notice-and-comment rulemaking to de-
14
fine the term ‘patient’ with respect to covered 
15
entities described in subparagraph (L) or (M) 
16
of subsection (a)(4) to reflect the requirements 
17
described in subparagraphs (A) and (B) of this 
18
paragraph. 
19
‘‘(D) DEFINITION
RELATING
TO
OTHER 
20
COVERED ENTITIES.—In this section, the term 
21
‘patient’, with respect to a covered entity de-
22
scribed in subparagraphs (A) through (K) of 
23
subsection (a)(4), has the meaning given such 
24
term in the October 24, 1996, HRSA Final No-
25
18:53 Mar 21, 2019
H1559
6 
•HR 1559 IH
tice Regarding Section 602 of the Veterans 
1
Health Care Act of 1992 Patient and Entity 
2
Eligibility (61 Fed Reg. 55156). 
3
‘‘(E) RECORD RETENTION.—A covered en-
4
tity described in subparagraph (L) or (M) of 
5
subsection (a)(4) shall retain auditable health 
6
care records which demonstrate the existence of 
7
a patient relationship in accordance with this 
8
paragraph for each prescription or order for a 
9
rolling period of not less than five years, or 
10
longer to the extent required by State or Fed-
11
eral law.’’. 
12
(b) TREATMENT OF CONTRACTED SERVICES.—Sub-
13
section (a) of section 340B of the Public Health Service 
14
Act (42 U.S.C. 256b) is amended by adding at the end 
15
the following new paragraphs: 
16
‘‘(11) CONTRACTED SERVICES.—In the case of 
17
a covered entity described in subparagraph (L) or 
18
(M) of subsection (a)(4) that elects to enter into a 
19
contractual arrangement with a third party for serv-
20
ices related to the drug discount program under this 
21
section, such as to dispense covered outpatient drugs 
22
subject to an agreement under this section to pa-
23
tients of the covered entity, to administer contracted 
24
pharmacy services, or to provide any other service 
25
18:53 Mar 21, 2019
H1559
7 
•HR 1559 IH
related to the drug discount program under this sec-
1
tion, the remuneration for which is based in whole 
2
or in part on the volume of dispensed covered out-
3
patient drugs subject to an agreement under this 
4
section, such covered entity shall— 
5
‘‘(A) have a contractual agreement in place 
6
between the covered entity and each contracted 
7
entity, including with each location of a phar-
8
macy contracted to dispense covered outpatient 
9
drugs subject to an agreement under this sec-
10
tion to patients (as so defined) of the covered 
11
entity, which shall specify that the contracted 
12
entity shall adhere to all requirements of the 
13
drug discount program under this section, but 
14
that ultimate responsibility for program compli-
15
ance and oversight of compliance by each con-
16
tracted entity shall remain with the covered en-
17
tity and that all covered outpatient drugs sub-
18
ject to an agreement under this section shall be 
19
purchased by the covered entity; 
20
‘‘(B) register each such agreement with 
21
the Secretary, include in such registration such 
22
information as shall be specified by the Sec-
23
retary, and make available such agreement 
24
upon request by the Secretary; 
25
18:53 Mar 21, 2019
H1559
8 
•HR 1559 IH
‘‘(C) ensure the compliance of each such 
1
agreement with the requirements of this section 
2
to prevent drug diversion in violation of sub-
3
paragraph (B) of paragraph (5) and to prevent 
4
duplicate discounts in violation of subparagraph 
5
(A) of such paragraph before utilizing the serv-
6
ices of the contracted entity, including by— 
7
‘‘(i) developing and implementing, 
8
with each contracted entity subject to such 
9
an agreement, a system to verify eligibility 
10
of patients (as so defined) of the entity; 
11
‘‘(ii) developing and implementing, 
12
with each such contracted entity, a mecha-
13
nism for tracking the inventory of covered 
14
outpatient drugs that are subject to an 
15
agreement under this section that is suit-
16
able to prevent diversion in violation of 
17
subparagraph (B) of paragraph (5) and to 
18
prevent duplicate discounts in violation of 
19
subparagraph (A) of such paragraph, such 
20
as a separate inventory for such drugs; 
21
and 
22
‘‘(iii) establishing a mechanism with 
23
each such contracted entity and each appli-
24
cable State Medicaid agency that is suit-
25
18:53 Mar 21, 2019
H1559
9 
•HR 1559 IH
able to prevent duplicate discounts for cov-
1
ered outpatient drugs that are subject to 
2
an agreement under this section, including 
3
such drugs dispensed to enrollees of Med-
4
icaid managed care organizations, and 
5
complies with regulations on methodologies 
6
to prevent duplicate discounts issued by 
7
the Secretary; 
8
‘‘(D) make available, to the extent the cov-
9
ered entity offers a charity care policy or has 
10
an obligation under subsection (a)(5)(E) to 
11
have a sliding fee scale, patient access to a cov-
12
ered entity’s prescription drug charity care ben-
13
efit and its sliding fee scale, and developing and 
14
implementing, with each such contracted entity, 
15
a mechanism for documenting the income and 
16
insurance status of each patient (as so defined) 
17
of the covered entity and the amount each such 
18
patient pays to receive covered outpatient drugs 
19
that are subject to an agreement under this sec-
20
tion; 
21
‘‘(E) maintain, and ensure that each such 
22
contracted entity maintains, auditable records 
23
that pertain to the compliance of the covered 
24
entity and the contracted entity with the re-
25
18:53 Mar 21, 2019
H1559
10 
•HR 1559 IH
quirements described in this paragraph, for a 
1
rolling period of not less than 5 years; 
2
‘‘(F) establish a process for, and conduct, 
3
periodic comparisons of the covered entity’s pre-
4
scribing records with the dispensing records of 
5
each such contracted entity, as applicable, to 
6
detect potential irregularities and to ensure that 
7
all drugs dispensed by the contracted entity are 
8
for patients (as so defined) of the covered enti-
9
ty; 
10
‘‘(G) provide for annual on-site audits of 
11
each such contracted entity to be conducted by 
12
an independent outside auditor; 
13
‘‘(H) maintain arrangements to dispense 
14
covered outpatient drugs that are subject to an 
15
agreement under this section to patients (as so 
16
defined) of the covered entity with no more 
17
than 5 contract pharmacy locations at any 
18
given time, all of which must be located within 
19
(or, for mail-order pharmacies, serve patients 
20
residing in) lower-income (using American 
21
Community Survey data as determined by the 
22
Secretary) census tracts served by the covered 
23
entity, except in the case that the covered entity 
24
files a publicly available exception request with 
25
18:53 Mar 21, 2019
H1559
11 
•HR 1559 IH
the Secretary that seeks authorization to estab-
1
lish a particular contract pharmacy arrange-
2
ment in a higher-income census tract and ex-
3
plains the reason in that particular case such a 
4
contract pharmacy would best meet the needs of 
5
low-income patients of the covered entity, and 
6
the Secretary decides to grant the request to es-
7
tablish one of the 5 contract pharmacies in the 
8
census tract requested; 
9
‘‘(I) ensure, as applicable, that patients (as 
10
so defined) of the covered entity have access to 
11
the covered entity’s prescription drug charity 
12
care benefit through each contract pharmacy lo-
13
cation at the time of purchase of each covered 
14
outpatient drug subject to an agreement under 
15
this section to the same extent such patients 
16
have access to the benefit with respect to such 
17
drugs purchased directly through the covered 
18
entity; and 
19
‘‘(J) limit any amount paid by the covered 
20
entity, or any agent of the covered entity, to the 
21
contracted entity for dispensing covered out-
22
patient drugs subject to an agreement under 
23
this section or for any other service related to 
24
the drug discount program under this section to 
25
18:53 Mar 21, 2019
H1559
12 
•HR 1559 IH
a reasonable amount, which shall not exceed the 
1
fair market value of such drug dispensing or 
2
other service. 
3
In the case the Secretary grants a request under 
4
subparagraph (H) to establish a particular contract 
5
pharmacy arrangement in a higher-income census 
6
tract, the Secretary shall make such decision avail-
7
able on a public website. 
8
‘‘(12) AUDITING.—A covered entity described in 
9
subparagraph (L) or (M) of subsection (a)(4) and a 
10
contracted entity that enter into a contractual ar-
11
rangement described in paragraph (11) shall per-
12
mit— 
13
‘‘(A) the Secretary to audit the records of 
14
the covered entity and of the contracted entity 
15
that pertain to the covered entity’s and the con-
16
tracted entity’s compliance with the require-
17
ments described in such paragraph; and 
18
‘‘(B) the manufacturer of a covered out-
19
patient drug that is subject to an agreement 
20
under this section (or its designee) to audit 
21
such records of the covered entity and of the 
22
contracted entity solely with respect to such 
23
drugs of the manufacturer. 
24
‘‘(13) REGULATIONS.— 
25
18:53 Mar 21, 2019
H1559
13 
•HR 1559 IH
‘‘(A) Not later than 180 days after the 
1
date of enactment of this paragraph, the Sec-
2
retary 
shall 
promulgate 
final 
regulations 
3
through notice-and-comment rulemaking to im-
4
plement the requirements of paragraph (11) 
5
and paragraph (12). Such regulations shall in-
6
clude model terms for the contractual agree-
7
ment described in subparagraph (A) of para-
8
graph (11). 
9
‘‘(B) Not later than 180 days after the 
10
date of enactment of this paragraph, the Sec-
11
retary 
shall 
promulgate 
final 
regulations 
12
through notice-and-comment rulemaking to es-
13
tablish procedures, in the case in which the Sec-
14
retary determines that a violation of the annual 
15
contract pharmacy independent on-site audit re-
16
quirement in subparagraph (F) of paragraph 
17
(11), with respect to a contract pharmacy ar-
18
rangement, was knowing and intentional— 
19
‘‘(i) for removing the contract phar-
20
macy arrangement from a covered entity’s 
21
contract pharmacy network and disquali-
22
fying the entity from adding any additional 
23
contract pharmacies for a reasonable pe-
24
18:53 Mar 21, 2019
H1559
14 
•HR 1559 IH
riod, to be determined by the Secretary, of 
1
not less than two years; and 
2
‘‘(ii) for requiring that the entity pay 
3
a monetary penalty to a manufacturer or 
4
manufacturers in the form of interest on 
5
sums that are owed to the manufacturer 
6
due to violations of subparagraph (A) or 
7
(B) of subsection (a)(5) that occurred at 
8
one or more contract pharmacies and that 
9
were discovered later than such violations 
10
would have been if the entity had complied 
11
with its obligation to have annual inde-
12
pendent audits of contract pharmacies con-
13
ducted. 
14
‘‘(14) MAIL
ORDER
STUDY
AND
REGULA-
15
TIONS.— 
16
‘‘(A) REPORT.—Not later than 180 days 
17
after the date of the enactment of this para-
18
graph, the Secretary shall conduct a study (and 
19
submit to Congress a report containing the re-
20
sults of such study) regarding compliance con-
21
cerns associated with covered entities described 
22
in subparagraph (L) or (M) of subsection (a)(4) 
23
contracting with mail order pharmacies to dis-
24
pense covered outpatient drugs subject to an 
25
18:53 Mar 21, 2019
H1559
15 
•HR 1559 IH
agreement under this section, and any addi-
1
tional safeguards or limitations necessary and 
2
appropriate to reduce those compliance con-
3
cerns. 
4
‘‘(B) REGULATIONS.—Not later than 180 
5
days after the submission of the report under 
6
subparagraph (A), the Secretary shall promul-
7
gate final regulations applicable to covered enti-
8
ties described in such subparagraph, through 
9
notice-and-comment rulemaking, to implement 
10
any additional safeguards or limitations rec-
11
ommended by the study. 
12
‘‘(15) CONTRACT
PHARMACY
MORATORIUM.— 
13
No covered entity described in subparagraphs (L) or 
14
(M) of subsection (a)(4) shall enter into a new or ex-
15
panded contractual arrangement pursuant to which 
16
a third party dispenses covered outpatient drugs 
17
subject to an agreement under this section to pa-
18
tients (as so defined) of the covered entity during 
19
the period beginning on the date of the enactment 
20
of this paragraph and ending on the latter of— 
21
‘‘(A) the effective date of final regulations 
22
described in paragraph (13); 
23
‘‘(B) the effective date of final regulations 
24
described in paragraph (14); 
25
18:53 Mar 21, 2019
H1559
16 
•HR 1559 IH
‘‘(C) the effective date of final regulations 
1
issued through Secretarial notice-and-comment 
2
rulemaking that take into consideration the 
3
findings and recommendations in the report 
4
from the Inspector General of the Department 
5
of Health and Human Services required under 
6
subsection (g)(3).’’. 
7
(c) REGULATIONS TO REDUCE DUPLICATE DIS-
8
COUNT RISKS.—Subsection (a)(5)(A) of section 340B of 
9
the Public Health Service Act (42 U.S.C. 256b) is amend-
10
ed by adding at the end the following new clause: 
11
‘‘(iii) Not later than one year after 
12
the date of the enactment of this clause, 
13
the Secretary shall promulgate final regu-
14
lations through notice-and-comment rule-
15
making, describing methodologies for State 
16
Medicaid programs and all covered entities 
17
under subsection (a)(4) to identify and bill 
18
drugs subject to an agreement under this 
19
section in a manner that ensures compli-
20
ance with 340B Program prohibitions re-
21
garding duplicate discounts, including the 
22
duplicate discount prohibition under sec-
23
tion 1927(j)(1) of the Social Security Act, 
24
to include the application of such prohibi-
25
18:53 Mar 21, 2019
H1559
17 
•HR 1559 IH
tions to Medicaid managed care enrollees. 
1
Such methodologies shall include the use of 
2
340B-specific claims identifiers, and the 
3
provision of claims-level data by covered 
4
entities to States as well as manufacturers 
5
of covered outpatient drugs sufficient to 
6
identify claims that include drugs subject 
7
to an agreement under this section and to 
8
prevent duplicate discounts.’’. 
9
(d) AMOUNT
CHARGED
TO
LOW-INCOME
PA-
10
TIENTS.— 
11
(1) IN GENERAL.—Subsection (a)(5) of section 
12
340B of the Public Health Service Act (42 U.S.C. 
13
256b) is amended by adding at the end the following 
14
new subparagraphs: 
15
‘‘(E) AMOUNT CHARGED TO LOW-INCOME 
16
PATIENTS.—As a condition of certification or 
17
recertification under subparagraph (E) of para-
18
graph (7), each covered entity described in sub-
19
paragraph (L) or (M) of subsection (a)(4) must 
20
establish a sliding scale fee schedule for pro-
21
viding covered outpatient drugs that are subject 
22
to an agreement under this section, directly or 
23
under a contractual arrangement pursuant to 
24
18:53 Mar 21, 2019
H1559
18 
•HR 1559 IH
which a third party dispenses such drugs, to 
1
patients of the covered entity who are— 
2
‘‘(i) low-income individuals; and 
3
‘‘(ii) not covered under minimum es-
4
sential coverage, as defined in section 
5
5000A(f) of the Internal Revenue Code. 
6
‘‘(F) REGULATIONS.—Not later than 180 
7
days after the date of enactment of this sub-
8
paragraph, the Secretary shall promulgate final 
9
regulations through notice-and-comment rule-
10
making, to implement the requirements under 
11
subparagraph (E). Such regulations shall— 
12
‘‘(i) define the term ‘low-income indi-
13
vidual’; 
14
‘‘(ii) provide a methodology for estab-
15
lishing the sliding scale fee schedule, which 
16
shall apply, where otherwise applicable to a 
17
covered entity, regardless of whether the 
18
covered outpatient drug is dispensed by the 
19
covered entity directly or a child site of the 
20
covered entity or by a contracted entity de-
21
scribed in paragraph (11); and 
22
‘‘(iii) ensure the security and protec-
23
tion of privileged or otherwise confidential 
24
18:53 Mar 21, 2019
H1559
19 
•HR 1559 IH
data from unauthorized disclosure or re- 
1
disclosure.’’. 
2
(e) PRIVATE NON-PROFIT DSH HOSPITALS
AND 
3
OUTPATIENT HOSPITAL FACILITIES.— 
4
(1) DEFINITION.—Subparagraph (L) of section 
5
340B(a)(4) of the Public Health Service Act (42 
6
U.S.C. 256b(a)(4)) is amended to read as follows: 
7
‘‘(L) A subsection (d) hospital (as defined 
8
in section 1886(d)(1)(B) of the Social Security 
9
Act) that— 
10
‘‘(i) is— 
11
‘‘(I) owned or operated by a unit 
12
of State or local government; 
13
‘‘(II) a public or private non- 
14
profit corporation which is formally 
15
granted governmental powers by a 
16
unit of State or local government; or 
17
‘‘(III) a private non-profit hos-
18
pital which has a contract with a 
19
State or local government to provide 
20
health care services, which include the 
21
ordering or prescribing of covered out-
22
patient drugs that are subject to an 
23
agreement under this section, to low- 
24
income individuals who are not enti-
25
18:53 Mar 21, 2019
H1559
20 
•HR 1559 IH
tled to benefits under title XVIII of 
1
the Social Security Act or eligible for 
2
assistance under the State plan for 
3
medical assistance under title XIX of 
4
such Act; 
5
‘‘(ii) for the most recent cost report-
6
ing period that ended before the calendar 
7
quarter involved, had a disproportionate 
8
share adjustment percentage (as deter-
9
mined under section 1886(d)(5)(F) of the 
10
Social Security Act) greater than 11.75 
11
percent or was described in section 
12
1886(d)(5)(F)(i)(II) of such Act; and 
13
‘‘(iii) does not obtain covered out-
14
patient drugs through a group purchasing 
15
organization or other group purchasing ar-
16
rangement. 
17
If the Secretary determines that a hospital that 
18
is eligible for participation in the 340B pro-
19
gram under this subparagraph obtained covered 
20
outpatient drugs through a group purchasing 
21
organization or another group purchasing ar-
22
rangement while that hospital was participating 
23
in the drug discount program under this sec-
24
tion, then the Secretary shall remove such hos-
25
18:53 Mar 21, 2019
H1559
21 
•HR 1559 IH
pital from such program and the hospital shall 
1
not be permitted to seek re-enrollment for a pe-
2
riod of at least 12 months after its removal 
3
from the program.’’. 
4
(2) STUDY AND REPORT; MORATORIUM; OUT-
5
PATIENT
HOSPITAL
FACILITIES; 
AUDITS.—Sub-
6
section (c) of section 340B of the Public Health 
7
Service Act (42 U.S.C. 256b) is amended to read as 
8
follows: 
9
‘‘(c) COVERED ENTITIES THAT ARE PRIVATE, NON- 
10
PROFIT DSH HOSPITALS.— 
11
‘‘(1) STUDY AND REPORT.— 
12
‘‘(A) STUDY.—The Comptroller General of 
13
the United States shall conduct a study on the 
14
relationship between the disproportionate share 
15
adjustment percentages of private covered enti-
16
ties described in subclauses (II) and (III) of 
17
subsection (a)(4)(L)(i) and the levels of charity 
18
care provided by such entities to outpatients. 
19
‘‘(B) REPORT.—Not later than 180 days 
20
after the date of enactment of the 340B Protec-
21
tion and Accountability Act of 2019, the Comp-
22
troller General shall submit to the appropriate 
23
committees of Congress a report on the results 
24
of the study conducted under subparagraph 
25
18:53 Mar 21, 2019
H1559
22 
•HR 1559 IH
(A), including recommendations on a metric 
1
that, as applied to a private covered entity de-
2
scribed in such subparagraph, reflects a high 
3
level of charity care provided to outpatients as 
4
a percentage of the covered entity’s overall ex-
5
penses for outpatient care, and could replace 
6
the metric described in subclause (ii) of sub-
7
section (a)(4)(L). The Comptroller General 
8
shall recommend the metric that best aligns 
9
with the level of charity care provided to out-
10
patients as a percentage of overall hospital op-
11
erating expenses on outpatient care if no metric 
12
is identified that provides a precise measure of 
13
such percentage. 
14
‘‘(2) MORATORIUM.— 
15
‘‘(A) IN
GENERAL.—For the period de-
16
scribed in subparagraph (B)— 
17
‘‘(i) a private covered entity described 
18
in subclauses (II) or (III) of subsection 
19
(a)(4)(L)(i) may participate in the drug 
20
discount program under this section as a 
21
covered entity only if it was properly en-
22
rolled as a covered entity in the drug dis-
23
count program under this section as of the 
24
date of the enactment of the 340B Protec-
25
18:53 Mar 21, 2019
H1559
23 
•HR 1559 IH
tion and Accountability Act of 2019 and 
1
continuously enrolled thereafter; and 
2
‘‘(ii) with respect to a facility or orga-
3
nization described in paragraph (3) of this 
4
subsection that is wholly owned by a pri-
5
vate covered entity described in subclause 
6
(II) or (III) of subsection (a)(4)(L)(i), only 
7
a facility or organization that was properly 
8
enrolled as a child site in the drug discount 
9
program under this section as of the date 
10
of the enactment of the 340B Protection 
11
and Accountability Act of 2019 and con-
12
tinuously enrolled thereafter may partici-
13
pate in the drug discount program under 
14
this section. 
15
‘‘(B) PERIOD DESCRIBED.—For purposes 
16
of subparagraph (A), the period described in 
17
this subparagraph is the period beginning on 
18
the date of enactment of the 340B Protection 
19
and Accountability Act of 2019 and ending on 
20
the effective date described in subparagraph 
21
(C). 
22
‘‘(C) EFFECTIVE DATE OF REPLACEMENT 
23
METRIC.— 
24
18:53 Mar 21, 2019
H1559
24 
•HR 1559 IH
‘‘(i) IN
GENERAL.—For purposes of 
1
subparagraph (B), subject to clause (ii), 
2
the effective date described in this sub-
3
paragraph is the effective date specified in 
4
legislation that, with respect to private cov-
5
ered entities described in subclauses (II) 
6
and (III) of subsection (a)(4)(L)(i)— 
7
‘‘(I) replaces the metric described 
8
in clause (ii) of subsection (a)(4)(L) 
9
with a metric that more accurately re-
10
flects the levels of outpatient charity 
11
care as a percentage of overall ex-
12
penses for outpatient care provided by 
13
such entities; and 
14
‘‘(II) takes into account the re-
15
port submitted under paragraph (1), 
16
including by addressing the Comp-
17
troller General’s recommendations in-
18
cluded in such report. 
19
‘‘(ii) EXCEPTION.—If legislation de-
20
scribed in clause (i) is not enacted by the 
21
date that is one year after the date of sub-
22
mission of the report under paragraph 
23
(1)— 
24
18:53 Mar 21, 2019
H1559
25 
•HR 1559 IH
‘‘(I) the Secretary shall promul-
1
gate final regulations that implement, 
2
to the extent practicable, the Comp-
3
troller General’s recommendations in-
4
cluded within such report not later 
5
than the date that is 180 days after 
6
such one-year date; and 
7
‘‘(II) for purposes of subpara-
8
graph (B), the effective date described 
9
in this subparagraph is the effective 
10
date of such final regulations. 
11
‘‘(3) OUTPATIENT
HOSPITAL
FACILITIES.—A 
12
facility or organization may participate in the drug 
13
discount program under this section as a child site 
14
of a covered entity described in subparagraph (L) or 
15
(M) of subsection (a)(4) only if such facility or orga-
16
nization— 
17
‘‘(A) is wholly owned by a covered entity 
18
described in subparagraph (L) or (M) of sub-
19
section (a)(4); 
20
‘‘(B) except in the case in which the parent 
21
covered entity is a children’s hospital described 
22
in subparagraph (M) of subsection (a)(4) which 
23
does not file a Medicare cost report, is listed on 
24
the Medicare cost report most recently filed by 
25
18:53 Mar 21, 2019
H1559
26 
•HR 1559 IH
the parent covered entity on a line that is reim-
1
bursable under this title, if such cost report 
2
demonstrates that the services provided at the 
3
facility or organization have associated out-
4
patient costs and charges under this title, and 
5
if the parent covered entity has provided a copy 
6
of such cost report to the Office of Pharmacy 
7
Affairs of the Health Resources and Services 
8
Administration; 
9
‘‘(C) in the case that the parent covered 
10
entity is a children’s hospital described in sub-
11
paragraph (M) of subsection (a)(4) which does 
12
not file a Medicare cost report, would be cor-
13
rectly included on a reimbursable line with as-
14
sociated outpatient costs and charges under 
15
title XVIII on a Medicare cost report of the 
16
parent covered entity, if filed, and the parent 
17
covered entity authorizing official has submitted 
18
a signed statement to the Secretary which cer-
19
tifies the foregoing and that the requested out-
20
patient facility is an integral part of the chil-
21
dren’s hospital and is providing health care 
22
services to patients of such hospital; 
23
‘‘(D) meets the provider-based status re-
24
quirements under section 413.65 of title 42, 
25
18:53 Mar 21, 2019
H1559
27 
•HR 1559 IH
Code of Federal Regulations or under any suc-
1
cessor to such section; 
2
‘‘(E) provides outpatient health care serv-
3
ices and is not limited to providing only drugs 
4
or drug administration; 
5
‘‘(F) provides a level of free or discounted 
6
health care services to individuals who meet the 
7
parent covered entity’s criteria for financial as-
8
sistance and are unable to pay for all or a por-
9
tion of the services, as reported at cost to the 
10
Internal 
Revenue 
Service 
under 
section 
11
501(r)(4) of the Internal Revenue Code for the 
12
calendar year, that is similar to that of the par-
13
ent covered entity; and 
14
‘‘(G) adheres to the parent covered entity’s 
15
sliding scale fee schedule for providing covered 
16
outpatient drugs that are subject to an agree-
17
ment under this section to patients who are (i) 
18
low-income individuals; and (ii) not covered 
19
under minimum essential coverage, as defined 
20
in section 5000A(f) of the Internal Revenue 
21
Code. Such sliding fee schedules must be made 
22
publicly available in a similar manner to a 
23
501(c)(3) hospital’s financial assistance policy 
24
18:53 Mar 21, 2019
H1559
28 
•HR 1559 IH
as required under section 501(r) of the Internal 
1
Revenue Code of 1986. 
2
‘‘(4) CERTIFICATION AND AUDITING.— 
3
‘‘(A) A covered entity described in sub-
4
clause (III) of subsection (a)(4)(L)(i) shall— 
5
‘‘(i) not less than annually, provide to 
6
the Secretary a certification executed by 
7
the hospital’s 340B Program authorizing 
8
official and an appropriate government of-
9
ficial (such as the governor, county execu-
10
tive, mayor, or an individual authorized to 
11
represent and bind the governmental enti-
12
ty), certifying that— 
13
‘‘(I) a contract is currently in 
14
force between such covered entity and 
15
the State or local government to pro-
16
vide health care services, to include 
17
direct medical care and the ordering 
18
or prescribing of covered outpatient 
19
drugs that are subject to an agree-
20
ment under this section, to low-income 
21
individuals who are not entitled to 
22
benefits under title XVIII of the So-
23
cial Security Act or eligible for assist-
24
18:53 Mar 21, 2019
H1559
29 
•HR 1559 IH
ance under the State plan under title 
1
XIX of such Act; 
2
‘‘(II) such contract creates en-
3
forceable expectations for such cov-
4
ered entity for the provision of the 
5
health care services described in sub-
6
clause (I) to the individuals described 
7
in such subclause; and 
8
‘‘(III) the health care services de-
9
scribed in subclause (I) represent a 
10
significant portion of the hospital’s 
11
operating revenues, and are not for 
12
services the covered entity is otherwise 
13
obligated to provide under State or 
14
Federal law; 
15
‘‘(ii) make available the contract de-
16
scribed in subclause (III) of subsection 
17
(a)(4)(L)(i) to the Secretary for publica-
18
tion on the public internet website of the 
19
Department of Health and Human Serv-
20
ices relating to this section; and 
21
‘‘(iii) permit the Secretary to audit 
22
the records of the covered entity that per-
23
tain to its compliance with the require-
24
18:53 Mar 21, 2019
H1559
30 
•HR 1559 IH
ments described in subclause (III) of sub-
1
section (a)(4)(L)(i) and this subparagraph. 
2
‘‘(B) A facility or organization that partici-
3
pates in the drug discount program under this 
4
section pursuant to paragraph (3) shall permit 
5
the Secretary to audit the records of such facil-
6
ity or organization that pertain to its compli-
7
ance with the requirements described in such 
8
paragraph. 
9
‘‘(C) The Secretary shall issue guidelines 
10
to implement the requirements described in this 
11
paragraph, which shall, at a minimum, define 
12
the term ‘low-income individuals’ for purposes 
13
of subclause (I) of subparagraph (A)(i), and 
14
identify the applicable methodology and thresh-
15
old for determining that the health care services 
16
described in such subclause represent a signifi-
17
cant portion of the hospital’s operating reve-
18
nues.’’. 
19
(f) REPORTING REQUIREMENTS.—Section 340B of 
20
the Public Health Service Act (42 U.S.C. 256b) is amend-
21
ed by adding at the end the following new subsections: 
22
‘‘(f) REPORTING REQUIREMENTS FOR COVERED EN-
23
TITIES.— 
24
18:53 Mar 21, 2019
H1559
31 
•HR 1559 IH
‘‘(1) IN GENERAL.—A covered entity described 
1
in subparagraph (L) or (M) of subsection (a)(4) 
2
shall annually submit to the Secretary an electronic 
3
and searchable data report in a machine-readable 
4
format. Such report shall contain, with respect to 
5
the year covered by the report, information on— 
6
‘‘(A) the number and percentage of pa-
7
tients of the covered entity, disaggregated by 
8
insurance status (including at least the Medi-
9
care program under title XVIII of the Social 
10
Security Act, the Medicaid program under title 
11
XIX of such Act, the Children’s Health Insur-
12
ance Program under title XXI of such Act, the 
13
TRICARE program under chapter 55 of title 
14
10, United States Code, health insurance cov-
15
erage or a group health plan, and uninsured), 
16
and by the type of site of the dispensing of the 
17
covered outpatient drug subject to an agree-
18
ment under this section (parent covered entity, 
19
facility or organization described in subsection 
20
(c)(3), contracted entity described in subsection 
21
(a)(11)); 
22
‘‘(B) the aggregate amount of gross reim-
23
bursement received by the covered entity (cal-
24
culated before subtracting any administrative or 
25
18:53 Mar 21, 2019
H1559
32 
•HR 1559 IH
other fees using a methodology provided by the 
1
Secretary) for covered outpatient drugs subject 
2
to an agreement under this section, including 
3
reimbursement received through facilities or or-
4
ganizations described in subsection (c)(3) or 
5
pursuant to contractual arrangements described 
6
in subsection (a)(11); 
7
‘‘(C) the aggregate acquisition cost for cov-
8
ered outpatient drugs subject to an agreement 
9
under this section dispensed during the year; 
10
‘‘(D) the aggregate amount paid by the 
11
covered entity, or any agent of the covered enti-
12
ty, to contracted entities described in subsection 
13
(a)(11) for dispensing covered outpatient drugs 
14
subject to an agreement under this section or 
15
for any other service related to the drug dis-
16
count program under this section; 
17
‘‘(E) how the entity prevents duplicate dis-
18
counts under subparagraph (A) of subsection 
19
(a)(5) and drug diversion under subparagraph 
20
(B) of such subsection; 
21
‘‘(F) the volume of covered outpatient 
22
drugs subject to an agreement under this sec-
23
tion dispensed by the covered entity and, in the 
24
case of a covered entity that has entered into 
25
18:53 Mar 21, 2019
H1559
33 
•HR 1559 IH
a contractual arrangement pursuant to which a 
1
third party dispenses covered outpatient drugs 
2
subject to an agreement under this section to 
3
patients of the covered entity, by each such con-
4
tracted entity; 
5
‘‘(G) quantitative data in terms of the 
6
amount and percentage of charitable care, as 
7
such term is defined for purposes of Medicare 
8
cost reporting or other reporting requirements 
9
identified by the Secretary, provided to patients 
10
of the covered entity by the covered entity in 
11
the form of covered outpatient drugs subject to 
12
an agreement under this section; 
13
‘‘(H) the name of any third-party vendor 
14
or other similar entity (if any) that the covered 
15
entity retains to administer the covered entity’s 
16
inventory management system or contract phar-
17
macy arrangement; and 
18
‘‘(I) other reporting requirements as the 
19
Secretary determines is necessary or appro-
20
priate for effective management and oversight 
21
of the drug discount program under this sec-
22
tion. 
23
‘‘(2) TIMING OF FIRST REPORT.—The first re-
24
port submitted under paragraph (1) shall be sub-
25
18:53 Mar 21, 2019
H1559
34 
•HR 1559 IH
mitted not later than 18 months after the date of 
1
enactment of this subsection. 
2
‘‘(3) ATTESTATION.—Each report submitted 
3
under paragraph (1) shall be accompanied by an at-
4
testation, in a form and manner specified by the 
5
Secretary, that the information submitted in such 
6
report is complete and accurate. Such attestation 
7
shall be subject to section 1001 of title 18, United 
8
States Code. 
9
‘‘(4) SANCTIONS.—If the Secretary finds that a 
10
covered entity is in violation of the requirement 
11
under paragraph (1) and the Secretary determines 
12
that such violation was knowing and intentional, the 
13
Secretary shall remove the entity from the drug dis-
14
count program under this section and disqualify the 
15
entity from re-entry into such program for a reason-
16
able period of time to be determined by the Sec-
17
retary. 
18
‘‘(5) REGULATIONS.—Not later than 180 days 
19
after the date of enactment of this subsection, the 
20
Secretary shall promulgate final regulations through 
21
notice-and-comment rulemaking to implement the re-
22
quirements under paragraphs (1) through (4). 
23
‘‘(6) PUBLIC DATABASE.—The Secretary shall 
24
make the data reported by covered entities under 
25
18:53 Mar 21, 2019
H1559
35 
•HR 1559 IH
this subsection available to the public on the website 
1
of the Department of Health and Human Services in 
2
an electronic and searchable format, which shall 
3
make each category of data reported available both 
4
in the aggregate and broken down by parent covered 
5
entities, child sites, and contract pharmacies, but 
6
shall not identify specific parent covered entities, 
7
child sites, or contract pharmacies. 
8
‘‘(g) REPORTS TO CONGRESS.— 
9
‘‘(1) REPORT BY THE SECRETARY.—Not later 
10
than two years after the date of the enactment of 
11
this subsection, the Secretary shall submit to the 
12
Committee on Energy and Commerce of the House 
13
of Representatives and the Committee on Health, 
14
Education, Labor, and Pensions of the Senate a re-
15
port, which shall contain— 
16
‘‘(A) with respect to covered entities de-
17
scribed in subparagraph (L) or (M) of sub-
18
section (a)(4), the information contained in the 
19
first report submitted by such entities to the 
20
Secretary under subsection (f); and 
21
‘‘(B) a description of the audits conducted 
22
by the Secretary pursuant to subparagraph (C) 
23
of subsection (a)(5), including the methodology 
24
used for conducting such audits, the results of 
25
18:53 Mar 21, 2019
H1559
36 
•HR 1559 IH
such audits, and actions taken by the Secretary 
1
in response to such audits, as well as actions 
2
taken by the Secretary in response to audits 
3
conducted by manufacturers pursuant to such 
4
subparagraph. 
5
‘‘(2) REPORT
BY
THE
COMPTROLLER
GEN-
6
ERAL.—Not later than one year after the date of the 
7
enactment of this subsection, the Comptroller Gen-
8
eral of the United States shall submit to the Com-
9
mittee on Energy and Commerce of the House of 
10
Representatives and the Committee on Health, Edu-
11
cation, Labor, and Pensions of the Senate a report 
12
on the use by covered entities of contractual ar-
13
rangements pursuant to which a third party dis-
14
penses covered outpatient drugs subject to an agree-
15
ment under this section to patients of the covered 
16
entity, disaggregated by covered entity types and the 
17
physical distance of the contracted entity’s location 
18
from the respective parent covered entity location. 
19
‘‘(3) ANNUAL
REPORTS
BY
THE
INSPECTOR 
20
GENERAL.—Not later than July 1 of each year (be-
21
ginning with 2018), the Inspector General of the 
22
Department of Health and Human Services shall 
23
submit to appropriate committees of Congress a re-
24
port on the contractual arrangements between cov-
25
18:53 Mar 21, 2019
H1559
37 
•HR 1559 IH
ered entities and third parties described in para-
1
graph (11) of subsection (a), including the methods 
2
and amounts of remuneration exchanged between 
3
such covered entities and such contracted entities, 
4
and the extent to which contract pharmacies are im-
5
proving access to medicines by patients of such cov-
6
ered entities. The first such annual report shall in-
7
clude recommendations, as the Inspector General de-
8
termines appropriate, that address safeguards to re-
9
duce duplicate discounting and diversion within con-
10
tract pharmacy arrangements and reforms to ensure 
11
these arrangements are targeted exclusively at im-
12
proving access to medicines for low-income or vul-
13
nerable patients of covered entities. Subsequent re-
14
ports under this paragraph should continue to mon-
15
itor such issues and be updated as changes are made 
16
to the drug discount program under this section.’’. 
17
(g) USER FEES UNDER THE 340B DRUG DISCOUNT 
18
PROGRAM.—Section 340B of the Public Health Service 
19
Act (42 U.S.C. 256b), as previously amended, is further 
20
amended by adding at the end the following new sub-
21
section: 
22
‘‘(h) USER FEES.— 
23
‘‘(1) IN GENERAL.—Subject to paragraph (6), 
24
the Secretary shall assess and collect a user fee from 
25
18:53 Mar 21, 2019
H1559
38 
•HR 1559 IH
covered entities described in subparagraph (L), (M), 
1
(N), or (O) of subsection (a)(4). In carrying out this 
2
subsection, the Secretary shall not require manufac-
3
turers to collect any user fee or to administer the 
4
user fee program established under this subsection. 
5
‘‘(2) PAYMENT.—A covered entity described in 
6
subparagraph (L), (M), (N), or (O) of subsection 
7
(a)(4) shall pay to the Secretary a fee assessed 
8
under paragraph (1) by such date that is the later 
9
of— 
10
‘‘(A) the date of the certification or recer-
11
tification of the covered entity, as applicable; or 
12
‘‘(B) the date that is 30 days after the 
13
date of the enactment of an appropriations Act 
14
providing for the collection and obligation of 
15
fees under this subsection for a fiscal year. 
16
‘‘(3) AMOUNT OF FEE.—The amount of a fee 
17
under paragraph (1) shall be equal to the amount 
18
determined by the Secretary under paragraph (4). 
19
‘‘(4) DETERMINATION OF AMOUNT OF FEE.— 
20
‘‘(A) IN GENERAL.—The Secretary shall, 
21
not later than 180 days before the start of each 
22
fiscal year that begins after September 30, 
23
2019, establish, for the next fiscal year, the 
24
amount of the fee payable under this subsection 
25
18:53 Mar 21, 2019
H1559
39 
•HR 1559 IH
by a covered entity using purchase data sub-
1
mitted by covered entities described in para-
2
graph (1), and using data submitted by manu-
3
facturers on sales to covered entities of covered 
4
outpatient drugs subject to an agreement under 
5
this section, pursuant to regulations to be 
6
issued by the Secretary. Such amount, with re-
7
spect to a covered entity and year, shall not ex-
8
ceed 0.1 percent of the total paid during the 
9
previous year by such covered entity to manu-
10
facturers for purchases of covered outpatient 
11
drugs subject to an agreement under this sec-
12
tion. 
13
‘‘(5) USE OF FEES.— 
14
‘‘(A) IN
GENERAL.—Any fee collected 
15
under paragraph (1) shall be used for purposes 
16
of administering this section, enhancing pro-
17
gram integrity and oversight activities under 
18
this section (including through audits under 
19
this section of covered entities and manufactur-
20
ers), and promoting access to clinical and cost- 
21
effective pharmacy services among safety net 
22
clinics and hospitals that participate under this 
23
section, such as through— 
24
18:53 Mar 21, 2019
H1559
40 
•HR 1559 IH
‘‘(i) the development of a multi-func-
1
tional web-based system to collect fees 
2
under paragraph (1); 
3
‘‘(ii) the improvement of the integrity, 
4
transparency, security, and reliability of 
5
the Office of Pharmacy Affairs Informa-
6
tion System, including to ensure that the 
7
database continues to meet the needs of 
8
external stakeholders; and 
9
‘‘(iii) improvements to the compliance 
10
tool of the Office of Pharmacy Affairs, 
11
used to integrate all information related to 
12
covered entities and manufacturers with 
13
agreements under this section. 
14
‘‘(B) SUPPLEMENT NOT SUPPLANT.—Any 
15
fee collected under paragraph (1) shall be used 
16
to supplement and not supplant the amount 
17
otherwise provided in appropriations Acts to 
18
carry out this section. 
19
‘‘(6) AVAILABILITY OF FEES.—Fees authorized 
20
under paragraph (1) shall be collected and available 
21
for obligation only to the extent and in the amount 
22
provided in advance in appropriations Acts. Such 
23
fees are authorized to remain available until ex-
24
pended. 
25
18:53 Mar 21, 2019
H1559
41 
•HR 1559 IH
‘‘(7) REGULATIONS.—Not later than 180 days 
1
after the date of enactment of this subsection, the 
2
Secretary shall promulgate final regulations through 
3
notice-and-comment rulemaking to implement the 
4
user fee collection pursuant to this subsection. 
5
‘‘(8) OVERSIGHT OF USER FEE PROGRAM.— 
6
‘‘(A) STUDY.—The Inspector General of 
7
the Department of Health and Human Services 
8
shall conduct an annual review of the user fee 
9
program established by this subsection. 
10
‘‘(B) REPORT.—Not later than July 1 of 
11
each year (beginning with 2019), the Inspector 
12
General of the Department of Health and 
13
Human Services shall submit to the appropriate 
14
committees of Congress a report on the study 
15
conducted under subparagraph (A), together 
16
with such recommendations as the Inspector 
17
General determines appropriate.’’. 
18
(h) DIRECT-HIRE AUTHORITY.—Section 340B(d) of 
19
the Public Health Service Act (42 U.S.C. 256b(d)) is 
20
amended by adding at the end the following new para-
21
graph: 
22
‘‘(5) 
DIRECT-HIRE
AUTHORITY.—Notwith-
23
standing section 3304(a)(3) of title 5, United States 
24
Code, and sections 3309 through 3318 of such title, 
25
18:53 Mar 21, 2019
H1559
42 
•HR 1559 IH
and section 337 of title 5 of the Code of Federal 
1
Regulations (or any successor regulations), the Sec-
2
retary may, beginning on the date of the enactment 
3
of this paragraph, exercise direct-hire authority to 
4
appoint a minimum of ten qualified candidates to 
5
permanent positions within the competitive service in 
6
order to carry out management and oversight activi-
7
ties under this section.’’. 
8
(i) APPLICABILITY.—Except as otherwise indicated, 
9
the provisions of, including amendments made by, this Act 
10
shall not apply to covered entities defined under subpara-
11
graphs (A) through (K), (N), or (O) of subsection (a)(4). 
12
Æ 
18:53 Mar 21, 2019
H1559
